James P. Quinlan
Chief Financial Officer · Medicus Pharma Ltd.
- 2025
- Aug 13, 2025
- 2
Other insiders active in the same sector
No other insider has filed at James P. Quinlan's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- BVF PARTNERS L P - $173.67M in KYMR purchases and sales in the last 12 months
- BAKER BROS. ADVISORS LP - $172.50M in KYMR purchases and sales in the last 12 months
- Keith S. Manchester - $154.47M in ROIV purchases and sales in the last 12 months
- QVT Financial LP - $147.38M in ROIV purchases and sales in the last 12 months
- Daniel Allen Gold - $147.38M in ROIV purchases and sales in the last 12 months
- ULSE Inc. - $146.25M in ULS purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is James P. Quinlan?
James P. Quinlan is a corporate insider, tracked as Chief Financial Officer of Medicus Pharma Ltd. (MDCX). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did James P. Quinlan last file a Form 4?
The most recent primary Form 4 on record is dated 13 August 2025, one of 2 filings going back to 2025.